• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

免疫原性钴卟啉脂质双层的实验与计算观察:纳米域增强的抗原缔合

Experimental and Computational Observations of Immunogenic Cobalt Porphyrin Lipid Bilayers: Nanodomain-Enhanced Antigen Association.

作者信息

Federizon Jasmin, Feugmo Conrard Giresse Tetsassi, Huang Wei-Chiao, He Xuedan, Miura Kazutoyo, Razi Aida, Ortega Joaquin, Karttunen Mikko, Lovell Jonathan F

机构信息

Department of Biomedical Engineering, University at Buffalo, State University of New York, Buffalo, NY 14260, USA.

Department of Chemistry, the University of Western Ontario, London, ON N6A 3K7, Canada.

出版信息

Pharmaceutics. 2021 Jan 14;13(1):98. doi: 10.3390/pharmaceutics13010098.

DOI:10.3390/pharmaceutics13010098
PMID:33466686
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7828809/
Abstract

Cobalt porphyrin phospholipid (CoPoP) can incorporate within bilayers to enable non-covalent surface-display of antigens on liposomes by mixing with proteins bearing a polyhistidine tag (his-tag); however, the mechanisms for how this occurs are poorly understood. These were investigated using the his-tagged model antigen Pfs25, a protein antigen candidate for malaria transmission-blocking vaccines. Pfs25 was found to associate with the small molecule aquocobalamin, a form of vitamin B12 and a cobalt-containing corrin macrocycle, but without particle formation, enabling comparative assessment. Relative to CoPoP liposomes, binding and serum stability studies indicated a weaker association of Pfs25 to aquocobalamin or cobalt nitrilotriacetic acid (Co-NTA) liposomes, which have cobalt displayed in the aqueous phase on lipid headgroups. Antigen internalization by macrophages was enhanced with Pfs25 bound to CoPoP liposomes. Immunization in mice with Pfs25 bound to CoPoP liposomes elicited antibodies that recognized ookinetes and showed transmission-reducing activity. To explore the physical mechanisms involved, we employed molecular dynamics (MD) simulations of bilayers containing phospholipid, cholesterol, as well as either CoPoP or NTA-functionalized lipids. The results show that the CoPoP-containing bilayer creates nanodomains that allow access for a limited but sufficient amount of water molecules that could be replaced by his-tags due to their favorable free energy properties allowing for stabilization. The position of the metal center within the NTA liposomes was much more exposed to the aqueous environment, which could explain its limited capacity for stabilizing Pfs25. This study illustrates the impact of CoPoP-induced antigen particleization in enhancing vaccine efficacy, and provides molecular insights into the CoPoP bilayer properties that enable this.

摘要

钴卟啉磷脂(CoPoP)可以整合到双层膜中,通过与带有多组氨酸标签(his-tag)的蛋白质混合,实现抗原在脂质体上的非共价表面展示;然而,其发生机制尚不清楚。使用带有his-tag的模型抗原Pfs25(一种疟疾传播阻断疫苗的蛋白质抗原候选物)对此进行了研究。发现Pfs25与小分子水合钴胺素(维生素B12的一种形式,含钴的咕啉大环化合物)相关联,但未形成颗粒,从而能够进行比较评估。相对于CoPoP脂质体,结合和血清稳定性研究表明,Pfs25与水合钴胺素或次氮基三乙酸钴(Co-NTA)脂质体的结合较弱,后者的钴展示在脂质头部基团的水相中。巨噬细胞对Pfs25结合的CoPoP脂质体的抗原内化作用增强。用Pfs25结合的CoPoP脂质体免疫小鼠可引发识别动合子并具有传播减少活性的抗体。为了探索其中涉及的物理机制,我们对含有磷脂、胆固醇以及CoPoP或NTA功能化脂质的双层膜进行了分子动力学(MD)模拟。结果表明,含CoPoP的双层膜形成了纳米域,允许有限但足够数量的水分子进入,这些水分子可被his-tag取代,因为它们具有有利的自由能特性,能够实现稳定。NTA脂质体中金属中心的位置更暴露于水环境中,这可以解释其稳定Pfs25的能力有限。这项研究说明了CoPoP诱导的抗原颗粒化对提高疫苗效力的影响,并提供了关于实现这一作用的CoPoP双层膜特性的分子见解。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/de62/7828809/33b5d685faa6/pharmaceutics-13-00098-g010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/de62/7828809/73e40ea87f3b/pharmaceutics-13-00098-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/de62/7828809/4a8ab2efbeb9/pharmaceutics-13-00098-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/de62/7828809/7d693d5f3b07/pharmaceutics-13-00098-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/de62/7828809/c62747307104/pharmaceutics-13-00098-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/de62/7828809/5dea01fefd5f/pharmaceutics-13-00098-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/de62/7828809/f8c06a5524c0/pharmaceutics-13-00098-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/de62/7828809/bd6281f61e91/pharmaceutics-13-00098-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/de62/7828809/81619e39e7ee/pharmaceutics-13-00098-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/de62/7828809/404420243774/pharmaceutics-13-00098-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/de62/7828809/33b5d685faa6/pharmaceutics-13-00098-g010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/de62/7828809/73e40ea87f3b/pharmaceutics-13-00098-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/de62/7828809/4a8ab2efbeb9/pharmaceutics-13-00098-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/de62/7828809/7d693d5f3b07/pharmaceutics-13-00098-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/de62/7828809/c62747307104/pharmaceutics-13-00098-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/de62/7828809/5dea01fefd5f/pharmaceutics-13-00098-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/de62/7828809/f8c06a5524c0/pharmaceutics-13-00098-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/de62/7828809/bd6281f61e91/pharmaceutics-13-00098-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/de62/7828809/81619e39e7ee/pharmaceutics-13-00098-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/de62/7828809/404420243774/pharmaceutics-13-00098-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/de62/7828809/33b5d685faa6/pharmaceutics-13-00098-g010.jpg

相似文献

1
Experimental and Computational Observations of Immunogenic Cobalt Porphyrin Lipid Bilayers: Nanodomain-Enhanced Antigen Association.免疫原性钴卟啉脂质双层的实验与计算观察:纳米域增强的抗原缔合
Pharmaceutics. 2021 Jan 14;13(1):98. doi: 10.3390/pharmaceutics13010098.
2
Particle-based, Pfs230 and Pfs25 immunization is effective, but not improved by duplexing at fixed total antigen dose.基于粒子的、PfS230 和 PfS25 免疫接种是有效的,但在固定总抗原剂量下不会因双效而改善。
Malar J. 2020 Aug 28;19(1):309. doi: 10.1186/s12936-020-03368-5.
3
Lyophilized, antigen-bound liposomes with reduced MPLA and enhanced thermostability.冻干、抗原结合的脂质体,具有降低的 MPLA 和增强的热稳定性。
Int J Pharm. 2020 Nov 15;589:119843. doi: 10.1016/j.ijpharm.2020.119843. Epub 2020 Sep 2.
4
Antibody response of a particle-inducing, liposome vaccine adjuvant admixed with a Pfs230 fragment.与Pfs230片段混合的颗粒诱导脂质体疫苗佐剂的抗体反应。
NPJ Vaccines. 2020 Mar 18;5(1):23. doi: 10.1038/s41541-020-0173-x. eCollection 2020.
5
An Engineered Biomimetic MPER Peptide Vaccine Induces Weakly HIV Neutralizing Antibodies in Mice.一种工程仿生 MPER 肽疫苗在小鼠中诱导弱 HIV 中和抗体。
Ann Biomed Eng. 2020 Jul;48(7):1991-2001. doi: 10.1007/s10439-019-02398-8. Epub 2019 Dec 12.
6
A malaria vaccine adjuvant based on recombinant antigen binding to liposomes.基于与脂质体结合的重组抗原的疟疾疫苗佐剂。
Nat Nanotechnol. 2018 Dec;13(12):1174-1181. doi: 10.1038/s41565-018-0271-3. Epub 2018 Oct 8.
7
Immunogenicity of the Lyme disease antigen OspA, particleized by cobalt porphyrin-phospholipid liposomes.钴原卟啉磷脂脂质体颗粒化的莱姆病抗原 OspA 的免疫原性。
Vaccine. 2020 Jan 22;38(4):942-950. doi: 10.1016/j.vaccine.2019.10.073. Epub 2019 Nov 11.
8
Functionalization of cobalt porphyrin-phospholipid bilayers with his-tagged ligands and antigens.用带有组氨酸标签的配体和抗原对钴卟啉-磷脂双层进行功能化修饰。
Nat Chem. 2015 May;7(5):438-46. doi: 10.1038/nchem.2236. Epub 2015 Apr 20.
9
Development and characterization of Ni-NTA-bearing microspheres.含镍-氮三乙酸微球的制备与表征
Cytometry. 2002 Jul 1;48(3):136-45. doi: 10.1002/cyto.10124.
10
Development and characterization of novel carrier gel core liposomes based transmission blocking malaria vaccine.新型载药凝胶核心脂质体的研制及其作为传播阻断疟疾疫苗的特性。
J Control Release. 2009 Dec 3;140(2):157-65. doi: 10.1016/j.jconrel.2009.08.004. Epub 2009 Aug 15.

引用本文的文献

1
Combination of Molecular Dynamics Simulations and Machine Learning Reveals Structural Characteristics of Stereochemistry-Specific Interdigitation of Synthetic Monomycoloyl Glycerol Analogs.分子动力学模拟与机器学习相结合揭示了合成单分枝菌酸甘油类似物立体化学特异性交叉指化的结构特征。
J Chem Inf Model. 2025 Jul 28;65(14):7605-7618. doi: 10.1021/acs.jcim.5c00615. Epub 2025 Jul 3.
2
CoPoP liposomes displaying stabilized clade C HIV-1 Env elicit tier 2 multiclade neutralization in rabbits.展示稳定的 clade C HIV-1 Env 的 CoPoP 脂质体在兔体内引发 2 级多 clade 中和反应。
Nat Commun. 2024 Apr 11;15(1):3128. doi: 10.1038/s41467-024-47492-1.
3

本文引用的文献

1
SARS-CoV-2 RBD Neutralizing Antibody Induction is Enhanced by Particulate Vaccination.SARS-CoV-2 RBD 中和抗体的诱导可通过颗粒疫苗接种增强。
Adv Mater. 2020 Dec;32(50):e2005637. doi: 10.1002/adma.202005637. Epub 2020 Oct 28.
2
Lyophilized, antigen-bound liposomes with reduced MPLA and enhanced thermostability.冻干、抗原结合的脂质体,具有降低的 MPLA 和增强的热稳定性。
Int J Pharm. 2020 Nov 15;589:119843. doi: 10.1016/j.ijpharm.2020.119843. Epub 2020 Sep 2.
3
Particle-based, Pfs230 and Pfs25 immunization is effective, but not improved by duplexing at fixed total antigen dose.
Identification of Enhanced Vaccine Mimotopes for the p15E Murine Cancer Antigen.
鉴定 p15E 鼠源肿瘤抗原增强型疫苗模拟表位。
Cancer Res Commun. 2024 Apr 2;4(4):958-969. doi: 10.1158/2767-9764.CRC-23-0384.
4
Intranasal Immunization with Liposome-Displayed Receptor-Binding Domain Induces Mucosal Immunity and Protection against SARS-CoV-2.用脂质体展示的受体结合域进行鼻内免疫可诱导黏膜免疫并提供针对 SARS-CoV-2 的保护。
Pathogens. 2022 Sep 12;11(9):1035. doi: 10.3390/pathogens11091035.
5
Vaccine co-display of CSP and Pfs230 on liposomes targeting two Plasmodium falciparum differentiation stages.脂质体共展示 CSP 和 Pfs230 疫苗,针对疟原虫两个分化阶段。
Commun Biol. 2022 Aug 1;5(1):773. doi: 10.1038/s42003-022-03688-z.
6
Zinc associated nanomaterials and their intervention in emerging respiratory viruses: Journey to the field of biomedicine and biomaterials.锌基纳米材料及其对新兴呼吸道病毒的干预:迈向生物医学与生物材料领域的征程。
Coord Chem Rev. 2022 Apr 15;457:214402. doi: 10.1016/j.ccr.2021.214402. Epub 2022 Jan 25.
7
Smart Lipid-Based Nanosystems for Therapeutic Immune Induction against Cancers: Perspectives and Outlooks.用于癌症治疗性免疫诱导的智能脂质纳米系统:前景与展望
Pharmaceutics. 2021 Dec 23;14(1):26. doi: 10.3390/pharmaceutics14010026.
8
Virus-like particles against infectious disease and cancer: guidance for the nano-architect.病毒样颗粒对抗传染病和癌症:纳米结构设计的指导。
Curr Opin Biotechnol. 2022 Feb;73:346-354. doi: 10.1016/j.copbio.2021.09.012. Epub 2021 Oct 29.
9
Mechanistic Understanding from Molecular Dynamics in Pharmaceutical Research 2: Lipid Membrane in Drug Design.药物研究中分子动力学的机理理解2:药物设计中的脂质膜
Pharmaceuticals (Basel). 2021 Oct 19;14(10):1062. doi: 10.3390/ph14101062.
10
A liposome-displayed hemagglutinin vaccine platform protects mice and ferrets from heterologous influenza virus challenge.一种脂质体展示的血凝素疫苗平台可保护小鼠和雪貂免受异源流感病毒的挑战。
Proc Natl Acad Sci U S A. 2021 Jun 1;118(22). doi: 10.1073/pnas.2025759118.
基于粒子的、PfS230 和 PfS25 免疫接种是有效的,但在固定总抗原剂量下不会因双效而改善。
Malar J. 2020 Aug 28;19(1):309. doi: 10.1186/s12936-020-03368-5.
4
Antibody response of a particle-inducing, liposome vaccine adjuvant admixed with a Pfs230 fragment.与Pfs230片段混合的颗粒诱导脂质体疫苗佐剂的抗体反应。
NPJ Vaccines. 2020 Mar 18;5(1):23. doi: 10.1038/s41541-020-0173-x. eCollection 2020.
5
Permeability of membranes in the liquid ordered and liquid disordered phases.膜在有序相和无序相中的渗透性。
Nat Commun. 2019 Dec 9;10(1):5616. doi: 10.1038/s41467-019-13432-7.
6
Immunogenicity of the Lyme disease antigen OspA, particleized by cobalt porphyrin-phospholipid liposomes.钴原卟啉磷脂脂质体颗粒化的莱姆病抗原 OspA 的免疫原性。
Vaccine. 2020 Jan 22;38(4):942-950. doi: 10.1016/j.vaccine.2019.10.073. Epub 2019 Nov 11.
7
Engineering Biomaterials to Direct Innate Immunity.设计用于引导先天性免疫的生物材料。
Adv Ther (Weinh). 2019 Jun;2(6). doi: 10.1002/adtp.201800157. Epub 2019 Feb 27.
8
Metalloporphyrin Nanoparticles: Coordinating Diverse Theranostic Functions.金属卟啉纳米颗粒:协调多种诊疗功能
Coord Chem Rev. 2019 Jan 15;379:99-120. doi: 10.1016/j.ccr.2017.09.002. Epub 2017 Sep 22.
9
Cholesterol in phospholipid bilayers: positions and orientations inside membranes with different unsaturation degrees.磷脂双层膜中的胆固醇:不同不饱和程度的膜内位置和取向。
Soft Matter. 2018 Dec 19;15(1):78-93. doi: 10.1039/c8sm01937a.
10
Nanoparticle Vaccines Against Infectious Diseases.纳米颗粒疫苗防治传染病
Front Immunol. 2018 Oct 4;9:2224. doi: 10.3389/fimmu.2018.02224. eCollection 2018.